Published in Pain on December 01, 2004
Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov (2005) 1.68
Peripheral mechanisms of pain and analgesia. Brain Res Rev (2008) 1.55
Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol Pain (2007) 1.31
Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision. Mol Pain (2008) 1.13
Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest (2009) 1.00
Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog (2009) 0.95
Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis (2007) 0.93
Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury. PLoS One (2012) 0.91
Light-emitting diode therapy induces analgesia in a mouse model of postoperative pain through activation of peripheral opioid receptors and the L-arginine/nitric oxide pathway. Lasers Med Sci (2013) 0.91
Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control. Ther Clin Risk Manag (2005) 0.90
Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy. Diabetes (2012) 0.84
Molecular and cellular mechanisms that initiate pain and itch. Cell Mol Life Sci (2015) 0.84
CXCL10 controls inflammatory pain via opioid peptide-containing macrophages in electroacupuncture. PLoS One (2014) 0.84
Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. J Neurochem (2008) 0.84
Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions. Front Pharmacol (2013) 0.83
Activated polymorphonuclear cells promote injury and excitability of dorsal root ganglia neurons. Exp Neurol (2007) 0.83
CD11b+Ly6G- myeloid cells mediate mechanical inflammatory pain hypersensitivity. Proc Natl Acad Sci U S A (2015) 0.82
Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain. Mol Pain (2009) 0.81
Roles of Gr-1+ leukocytes in postincisional nociceptive sensitization and inflammation. Anesthesiology (2012) 0.80
Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides. J Neuroinflammation (2016) 0.75
Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain. Sci Rep (2016) 0.75
Neuroimmune Interaction in the Regulation of Peripheral Opioid-Mediated Analgesia in Inflammation. Front Immunol (2016) 0.75
Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain (2015) 3.82
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Attacking pain at its source: new perspectives on opioids. Nat Med (2003) 2.53
A stomatin-domain protein essential for touch sensation in the mouse. Nature (2006) 2.08
Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain. J Leukoc Biol (2006) 1.75
Thoracic epidural anesthesia attenuates hemorrhage-induced impairment of intestinal perfusion in rats. Anesthesiology (2003) 1.58
Effects of thoracic epidural anaesthesia on intestinal microvascular perfusion in a rodent model of normotensive endotoxaemia. Intensive Care Med (2004) 1.57
T lymphocytes containing β-endorphin ameliorate mechanical hypersensitivity following nerve injury. Brain Behav Immun (2010) 1.54
CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo. Brain Behav Immun (2007) 1.48
Intra-articular morphine for inflammatory pain. Reg Anesth Pain Med (2006) 1.41
TRPV1 acts as proton channel to induce acidification in nociceptive neurons. J Biol Chem (2004) 1.28
Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest (2008) 1.27
Disease-associated mutations in L1 CAM interfere with ligand interactions and cell-surface expression. Hum Mol Genet (2002) 1.26
A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting. Br J Haematol (2010) 1.25
Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol (2006) 1.11
Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology (2003) 1.10
Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology (2004) 1.09
Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells. FASEB J (2006) 1.09
Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res (2007) 1.07
Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharmacol Rev (2011) 1.07
Different mechanisms of intrinsic pain inhibition in early and late inflammation. J Neuroimmunol (2003) 1.06
Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain. Clin J Pain (2007) 1.01
Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest (2009) 1.00
Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain (2006) 0.99
Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol (2002) 0.99
Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16. J Immunother (2010) 0.99
Endothelin-1 potentiates capsaicin-induced TRPV1 currents via the endothelin A receptor. Exp Biol Med (Maywood) (2006) 0.99
Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments. Neuro Oncol (2013) 0.98
Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C. Mol Pain (2007) 0.97
Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology (2004) 0.97
The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment. Curr Med Res Opin (2013) 0.96
Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception. Anesthesiology (2004) 0.96
Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci (2006) 0.96
A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting. MAbs (2011) 0.95
Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A (2012) 0.95
Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. Eur J Neurosci (2004) 0.95
Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog (2009) 0.95
Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects. Brain Behav Immun (2009) 0.95
Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther (2003) 0.94
Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis (2007) 0.93
Leukocyte-derived opioid peptides and inhibition of pain. J Neuroimmune Pharmacol (2006) 0.93
Bio-inspired scale-like surface textures and their tribological properties. Bioinspir Biomim (2015) 0.93
Immune mechanisms in pain control. Anesth Analg (2002) 0.92
Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1. Mol Pharmacol (2013) 0.92
The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue. Heart Vessels (2014) 0.92
Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue. FASEB J (2012) 0.92
Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework. Protein Eng Des Sel (2009) 0.91
Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo. J Neuroimmunol (2007) 0.91
Inhibition of inflammatory pain by CRF at peripheral, spinal and supraspinal sites: involvement of areas coexpressing CRF receptors and opioid peptides. Neuropsychopharmacology (2007) 0.91
Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain. Br J Pharmacol (2004) 0.89
The K(+) channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia. EMBO Mol Med (2013) 0.89
Immunosuppressive effects of opioids--clinical relevance. J Neuroimmune Pharmacol (2011) 0.88
Modulation of peripheral endogenous opioid analgesia by central afferent blockade. Anesthesiology (2003) 0.88